DIANEAL 1mmol Calcium in 4.25% Glucose Peritoneal dialysis solution Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dianeal 1mmol calcium in 4.25% glucose peritoneal dialysis solution

vantive pty ltd - glucose, quantity: 42.5 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; magnesium chloride hexahydrate, quantity: 0.0508 g/l; calcium chloride dihydrate, quantity: 0.147 g/l - solution, dialysis - excipient ingredients: water for injections - dianeal pd-2, pd-4 and 1mmol calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

DIANEAL 1mmol Calcium in 2.5% Glucose Peritoneal  dialysis solution Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dianeal 1mmol calcium in 2.5% glucose peritoneal dialysis solution

vantive pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; magnesium chloride hexahydrate, quantity: 0.0508 g/l; calcium chloride dihydrate, quantity: 0.147 g/l - solution, dialysis - excipient ingredients: water for injections - dianeal pd-2, pd-4 and 1mmol calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

DIANEAL 1mmol Calcium in 1.5% Glucose Peritoneal  dialysis solution Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dianeal 1mmol calcium in 1.5% glucose peritoneal dialysis solution

vantive pty ltd - glucose; sodium chloride; sodium lactate; magnesium chloride hexahydrate; calcium chloride dihydrate - solution, dialysis - excipient ingredients: water for injections - dianeal pd-2, pd-4 and 1mmol calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

Accu-Chek Connect Online Diabetes Management System - Clinical data collection/management information application software Australien - Englisch - Department of Health (Therapeutic Goods Administration)

accu-chek connect online diabetes management system - clinical data collection/management information application software

roche diabetes care australia pty ltd - 57967 - clinical data collection/management information application software - the accu-chek? connect online diabetes management system is indicated for use by persons with diabetes or by healthcare professionals in the home or in healthcare facilities in conjunction with a number of commercially available accu-chek? meter systems and compatible accu-chek? insulin pump systems and accu-chek? health management devices. the software is intended to allow manual entry of data and the download of data from the above-mentioned devices to an online account where it can be saved, displayed, reviewed, analyzed, and evaluated by patients or healthcare professionals to support effective diabetes management.

PEDIATRIC INFUVITE MULTIPLE VITAMINS- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

pediatric infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5

sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years